Physician profile
Leo Semes
NPI 1134139587
$59,584.14
in general payments reported to CMS, 2019-2025
13 companies · $66.10 in 2025
The $66.10 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $11K · 2021: $9,314 · 2022: $2,460 · 2023: $48.89 · 2025: $66.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $31,532.98 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $22,181.19 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $2,551.39 | 2019 | |
| Reichert, INC. | $1,350.00 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $840.00 | 2019 | |
| Allergan, INC. | $336.93 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $155.79 | 2019-2020 | |
| Genentech, INC. | $150.00 | 2021 | |
| Alcon Vision LLC | $114.99 | 2023-2025 | Clareon |
| Aerie Pharmaceuticals, INC. | $111.40 | 2019 | |
| Sun Pharmaceutical Industries INC. | $108.90 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $84.77 | 2019 | |
| Optovue, INC. | $65.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Semes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.